What GLP-1 Vials Look Like and How to Read the Prescription Label Starting GLP-1 therapyor transitioning to a new formulationis an exciting step, but lets be honest: opening that package for the first time can be a little confusing
We discussed the IGF-1 and cancer-surveillance conversation in the post on tesamorelin for visceral fat, and the same principles apply here
Correlation doesnt equal causation, and while the GLP-1 timing aligns perfectly with HRV decline, other unmeasured factors could be contributing
This suggests that weight loss may continue to build beyond 12 months for some people
Energy begins returning as your body adapts to its new metabolic state
News provided by Eli Lilly and Company Sep 17, 2025, 09:00 ET For the primary endpoint, orforglipron lowered A1C by 2.2% vs